Linitis plastica surgery

Jump to navigation Jump to search

Linitis plastica Microchapters


Patient Information


Historical Perspective




Differentiating Linitis plastica from Other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms


Diagnostic study of choice

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound



Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Linitis plastica surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Linitis plastica surgery

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Linitis plastica surgery

CDC on Linitis plastica surgery

Linitis plastica surgery in the news

Blogs on Linitis plastica surgery

Directions to Hospitals Treating Linitis plastica

Risk calculators and risk factors for Linitis plastica surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]


Total gastrectomy is recommended for the management of local disease. However, it is important to note that patients with linitis plastica usually present at an advanced stage when metastasis has already occurred, surgery at this point is often not curative but rather improves the chances of survival. Surgical resection is not recommended among patients with metastatic linitis plastica, radiotherapy and chemotherapy are utilized instead.


Selection of the surgery

  • Pancreaticosplenectomy
  • Total gastrectomy with splenectomy

Lymph nodes resection

  • One of the most controversial areas in the surgical management of gastric cancer is the optimal extent of lymph node dissection.[3]
  • The draining lymph nodes for the stomach have been meticulously divided into 16 stations by Japanese surgeons; stations 1 to 6 are perigastric, and the remaining 10 are located adjacent to major vessels, behind the pancreas, and along the aorta.[4]

D1 lymphadenectomy

  • It refers to a dissection of only the perigastric lymph nodes.
  • A D1 lymphadenectomy is indicated for T1a tumors that do not meet the criteria for EMR/ ESD and for T1bN0 tumors that are histologically of differentiated type and 1.5 cm or smaller in diameter.

D2 lymphadenectomy

D3 dissection

Local palliative preocedures

Reconstruction after gastrectomy

Total gastrectomy

  • Roux-en-Y esophagojejunostomy[7]
  • Jejunal interposition
  • Double tract method

Video shows gastrectomy steps


  1. Kim JY, Ha TK, le Roux CW (2014). "Metabolic effects of gastrectomy with or without omentectomy in gastric cancer". Hepatogastroenterology. 61 (134): 1830–4. PMID 25436387.
  2. Japanese Gastric Cancer Association (2017). "Japanese gastric cancer treatment guidelines 2014 (ver. 4)". Gastric Cancer. 20 (1): 1–19. doi:10.1007/s10120-016-0622-4. PMC 5215069. PMID 27342689.
  3. Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF (2000). "Is gastric carcinoma different between Japan and the United States?". Cancer. 89 (11): 2237–46. PMID 11147594.
  4. Japanese Gastric Cancer Association (2011). "Japanese classification of gastric carcinoma: 3rd English edition". Gastric Cancer. 14 (2): 101–12. doi:10.1007/s10120-011-0041-5. PMID 21573743.
  5. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A; et al. (2008). "D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer". N Engl J Med. 359 (5): 453–62. doi:10.1056/NEJMoa0707035. PMID 18669424.
  6. Kikuchi S, Arai Y, Kobayashi N, Tsukamoto H, Shimao H, Sakakibara Y; et al. (2000). "Is extended lymphadenectomy valuable in palliatively gastrectomized patients with gastric cancer and simultaneous peritoneal metastasis?". Hepatogastroenterology. 47 (32): 563–6. PMID 10791239.
  7. Xiao JW, Liu ZL, Ye PC, Luo YJ, Fu ZM, Zou Q; et al. (2015). "Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction". World J Gastroenterol. 21 (34): 9999–10007. doi:10.3748/wjg.v21.i34.9999. PMC 4566393. PMID 26379405.